These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 29336868)

  • 1. The therapeutic potential of targeting the peripheral endocannabinoid/CB
    Tam J; Hinden L; Drori A; Udi S; Azar S; Baraghithy S
    Eur J Intern Med; 2018 Mar; 49():23-29. PubMed ID: 29336868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the endocannabinoid/CB1 receptor system for treating obesity in Prader-Willi syndrome.
    Knani I; Earley BJ; Udi S; Nemirovski A; Hadar R; Gammal A; Cinar R; Hirsch HJ; Pollak Y; Gross I; Eldar-Geva T; Reyes-Capo DP; Han JC; Haqq AM; Gross-Tsur V; Wevrick R; Tam J
    Mol Metab; 2016 Dec; 5(12):1187-1199. PubMed ID: 27900261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MECHANISMS IN ENDOCRINOLOGY: Endocannabinoids and metabolism: past, present and future.
    Simon V; Cota D
    Eur J Endocrinol; 2017 Jun; 176(6):R309-R324. PubMed ID: 28246151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CB
    Drori A; Gammal A; Azar S; Hinden L; Hadar R; Wesley D; Nemirovski A; Szanda G; Salton M; Tirosh B; Tam J
    Elife; 2020 Nov; 9():. PubMed ID: 33210603
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Hirsch S; Tam J
    Toxins (Basel); 2019 May; 11(5):. PubMed ID: 31096702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The emerging role of the endocannabinoid system in the pathogenesis and treatment of kidney diseases.
    Tam J
    J Basic Clin Physiol Pharmacol; 2016 May; 27(3):267-76. PubMed ID: 26280171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Energy balance regulation by endocannabinoids at central and peripheral levels.
    Quarta C; Mazza R; Obici S; Pasquali R; Pagotto U
    Trends Mol Med; 2011 Sep; 17(9):518-26. PubMed ID: 21816675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A patent update on cannabinoid receptor 1 antagonists (2015-2018).
    Amato G; Khan NS; Maitra R
    Expert Opin Ther Pat; 2019 Apr; 29(4):261-269. PubMed ID: 30889997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocannabinoid control of food intake and energy balance.
    Di Marzo V; Matias I
    Nat Neurosci; 2005 May; 8(5):585-9. PubMed ID: 15856067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re-visiting the Endocannabinoid System and Its Therapeutic Potential in Obesity and Associated Diseases.
    Richey JM; Woolcott O
    Curr Diab Rep; 2017 Sep; 17(10):99. PubMed ID: 28913816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The endocannabinoid system: a new target for the regulation of energy balance and metabolism.
    Després JP
    Crit Pathw Cardiol; 2007 Jun; 6(2):46-50. PubMed ID: 17667864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel peripheral cannabinoid receptor 1 antagonist, BPR0912, reduces weight independently of food intake and modulates thermogenesis.
    Hsiao WC; Shia KS; Wang YT; Yeh YN; Chang CP; Lin Y; Chen PH; Wu CH; Chao YS; Hung MS
    Diabetes Obes Metab; 2015 May; 17(5):495-504. PubMed ID: 25656402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocannabinoids and the control of energy homeostasis.
    Kunos G; Osei-Hyiaman D; Liu J; Godlewski G; Bátkai S
    J Biol Chem; 2008 Nov; 283(48):33021-5. PubMed ID: 18694938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The endocannabinoid system and the treatment of obesity.
    Pagotto U; Vicennati V; Pasquali R
    Ann Med; 2005; 37(4):270-5. PubMed ID: 16019725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The hepatic cannabinoid 1 receptor as a modulator of hepatic energy state and food intake.
    Cooper ME; Regnell SE
    Br J Clin Pharmacol; 2014 Jan; 77(1):21-30. PubMed ID: 23452341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical role of the endocannabinoid system in the regulation of food intake and energy metabolism, with phylogenetic, developmental, and pathophysiological implications.
    Viveros MP; de Fonseca FR; Bermudez-Silva FJ; McPartland JM
    Endocr Metab Immune Disord Drug Targets; 2008 Sep; 8(3):220-30. PubMed ID: 18782018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The endocannabinoid system role in the pathogenesis of obesity and depression].
    Zdanowicz A; Kaźmierczak W; Wierzbiński P
    Pol Merkur Lekarski; 2015 Jul; 39(229):61-6. PubMed ID: 26277182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Endocannabinoid system and energy metabolism: physiology and pathophysiology].
    Pagotto U; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):74S-82S. PubMed ID: 18773754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacotherapeutic targeting of the endocannabinoid signaling system: drugs for obesity and the metabolic syndrome.
    Vemuri VK; Janero DR; Makriyannis A
    Physiol Behav; 2008 Mar; 93(4-5):671-86. PubMed ID: 18155257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The endocannabinoid system, eating behavior and energy homeostasis: the end or a new beginning?
    Bermudez-Silva FJ; Viveros MP; McPartland JM; Rodriguez de Fonseca F
    Pharmacol Biochem Behav; 2010 Jun; 95(4):375-82. PubMed ID: 20347862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.